Morr F 5% Topical Solution: Effective Minoxidil for Hair Regrowth
| Product dosage: 60 ml | |||
|---|---|---|---|
| Package (num) | Per sprayer | Price | Buy |
| 1 | $100.20 | $100.20 (0%) | 🛒 Add to cart |
| 2 | $82.66 | $200.39 $165.32 (18%) | 🛒 Add to cart |
| 3 | $73.48 | $300.59 $220.43 (27%) | 🛒 Add to cart |
| 4 | $68.88 | $400.79 $275.54 (31%) | 🛒 Add to cart |
| 5 | $61.52
Best per sprayer | $500.98 $307.60 (39%) | 🛒 Add to cart |
Morr F 5% Topical Solution combines minoxidil 5% w/v with finasteride 0.1% w/v in an advanced ethanol-based vehicle, offering a dual-action approach to treating androgenetic alopecia in adult men. This prescription medication is clinically formulated to slow hair loss, stimulate regrowth, and improve hair density by targeting the underlying hormonal and follicular mechanisms responsible for pattern baldness. It is applied directly to the scalp, ensuring localized delivery with minimal systemic exposure, and is intended for long-term use under medical supervision to maintain therapeutic benefits.
Features
- Contains minoxidil 5% w/v and finasteride 0.1% w/v in a single topical solution
- Ethanol-propylene glycol base for enhanced cutaneous absorption and stability
- Prescription-only formulation ensuring appropriate patient selection and monitoring
- Convenient once or twice daily application regimen
- Available in 60 mL bottles with calibrated dropper for accurate dosing
Benefits
- Promotes hair regrowth by prolonging the anagen (growth) phase of the hair cycle
- Reduces scalp dihydrotestosterone (DHT) levels to prevent further follicular miniaturization
- Improves hair density and coverage in androgenetic alopecia patients
- Offers localized treatment with potentially reduced systemic side effects compared to oral formulations
- Provides a synergistic approach by combining two proven anti-alopecia agents
- Supports long-term maintenance of existing hair follicles
Common use
Morr F is primarily indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men aged 18-65 years. It is most effective for vertex (crown) baldness and may show benefits for anterior mid-scalp area hair loss. Patients typically begin noticing reduced hair shedding within 2-4 months of consistent use, with visible hair regrowth apparent after 4-6 months of continuous therapy. Maximum benefits are generally observed after approximately one year of regular application. The solution is not intended for use by women, particularly those who are or may become pregnant, due to the potential risk of finasteride exposure.
Dosage and direction
Apply 1 mL of Morr F twice daily directly to the dry scalp in the affected area using the provided dropper. The total daily dose should not exceed 2 mL. Gently massage into the scalp with fingertips to ensure even distribution. Wash hands thoroughly after application. Allow the solution to dry completely before going to bed or using headwear. Do not shampoo for at least four hours after application. Hair should be completely dry before application, and the scalp should be free of cuts, abrasions, or sunburn. Consistency in application is crucial for optimal results.
Precautions
- For external use on the scalp only; avoid contact with eyes, mucous membranes, and broken skin
- Monitor for increased hair loss during the initial 2-6 weeks of treatment (shedding phase)
- Discontinue use and consult a physician if skin irritation, redness, or itching persists or worsens
- Avoid in patients with history of hypersensitivity to minoxidil, finasteride, or any component of the formulation
- Use with caution in patients with cardiovascular disease, particularly those with hypertension or orthostatic hypotension
- Regular monitoring of blood pressure is recommended, especially during initial treatment phases
- Keep out of reach of children and pets
Contraindications
- Hypersensitivity to minoxidil, finasteride, or any component of the formulation
- Women who are pregnant, planning pregnancy, or breastfeeding
- Patients with a history of pheochromocytoma
- Patients with unexplained scalp lesions, inflammation, or skin conditions affecting the application area
- Concomitant use with topical corticosteroids or other topical medications unless directed by a physician
- Patients with a history of orthostatic hypotension or syncopal episodes
Possible side effects
Common side effects (≥1% of patients) include:
- Initial increased hair shedding (usually transient, occurring 2-6 weeks after initiation)
- Local scalp irritation, itching, dryness, or flaking
- Mild erythema or burning sensation at application site
Less common side effects (<1% of patients) may include:
- Hypertrichosis (unwanted facial or body hair growth)
- Dizziness, lightheadedness, or tachycardia
- Changes in hair texture or color
- Allergic contact dermatitis
- Edema, particularly periorbital
- Headache or fatigue
Rare systemic effects may include:
- Orthostatic hypotension
- Sexual dysfunction (decreased libido, erectile dysfunction)
- Breast tenderness or enlargement
Drug interaction
- Concomitant use with oral minoxidil may potentiate cardiovascular effects
- May interact with antihypertensive medications, potentially enhancing hypotensive effects
- Topical corticosteroids may increase systemic absorption when applied to same areas
- Use with caution with other topical agents that enhance cutaneous absorption
- Finasteride component may interact with 5-alpha reductase inhibitors
- No known interactions with oral contraceptives or hormone replacement therapy
Missed dose
If a dose is missed, apply the solution as soon as remembered unless it is nearly time for the next application. Do not double the dose to make up for a missed application. Resume the regular dosing schedule. Consistency is important for optimal results, but occasional missed doses are not likely to significantly impact long-term efficacy. If multiple doses are missed, therapeutic effects may diminish, and previous hair loss patterns may resume.
Overdose
Topical overdose may occur with application of excessive amounts or more frequent than recommended application. Symptoms may include severe hypotension, dizziness, tachycardia, headache, and fluid retention. Systemic absorption through compromised skin barrier may enhance these effects. In case of suspected overdose, discontinue use immediately and seek medical attention. Treatment is supportive and symptomatic. Monitor vital signs, particularly blood pressure and heart rate. Gastric lavage is not indicated for topical overdose unless ingestion has occurred.
Storage
Store at room temperature (15-30°C) in an upright position. Keep the bottle tightly closed when not in use. Protect from light and excessive heat. Do not freeze. Keep away from open flames or sources of ignition due to ethanol content. Discard any unused solution 4 months after opening. Do not transfer to other containers. Keep out of reach of children and pets.
Disclaimer
This product is a prescription medication and should be used only under the supervision of a qualified healthcare provider. The information provided here is for educational purposes only and does not replace professional medical advice. Individual results may vary. Not all users will experience the same degree of hair regrowth. Discontinue use and consult a physician if adverse reactions occur. This product is not intended for use by women or individuals under 18 years of age. Regular follow-up with a healthcare provider is recommended during treatment.
Reviews
Clinical studies demonstrate that approximately 60% of male patients with androgenetic alopecia show significant improvement in hair growth after 12 months of consistent use with Morr F 5% solution. Patient-reported outcomes indicate high satisfaction with hair density improvement and slowing of hair loss progression. Dermatological assessments confirm good tolerability profile with most adverse effects being mild and transient. Long-term studies (24 months) show maintained efficacy with continuous use and good adherence rates due to convenient twice-daily application regimen.